Form 4: Surrozen Director Eric Bjerkholt Reports Option Grant

Director Eric Bjerkholt reports the acquisition of options to purchase 1,333 shares of Surrozen, Inc. common stock.

Summary

• Eric Bjerkholt, a director of Surrozen, Inc., filed a Form 4 on May 15, 2025.
• The report details the grant of options to Bjerkholt on May 14, 2025.
• Bjerkholt acquired options to purchase 1,333 shares of common stock at an exercise price of $6.50.
• The options vest annually beginning May 14, 2026, subject to continuous service as a director, and expire on May 14, 2035.
• Following the transaction, Bjerkholt directly owns options for 1,333 shares of Surrozen common stock.

Sentiment

Score: 7

Explanation: The document reflects a standard executive compensation practice, indicating confidence in the company's future. It's a neutral to slightly positive event.

Positives

• The option grant aligns the director's interests with those of the shareholders.

Future Outlook

The options vest over time, incentivizing the director to contribute to the company's long-term success.

Industry Context

Option grants are a common form of executive compensation in the biotechnology industry, aligning management's interests with shareholder value creation.

Stakeholder Impact

• The option grant aligns the director's interests with those of the shareholders, potentially leading to better decision-making.

Key Dates

Keywords

Form 4, Surrozen, Director, Option Grant, Beneficial Ownership, SRZN, Equity Securities